1.Successful treatment with ganciclovir for cytomegalovirus duodenitis following allogenic bone marrow transplantation.
Jin Hee AHN ; Je Hwan LEE ; Kyoo Hyung LEE ; Woo Kun KIM ; Jung Shin LEE ; Hyeseung BAHNG ; Hwoon Yong JUNG ; Yang Soo KIM ; Onja KIM ; Sang Hee KIM
The Korean Journal of Internal Medicine 1999;14(1):91-94
Cytomegalovirus(CMV) disease is a major cause of morbidity and mortality in immunocompromised patients. CMV enteritis should be considered when nausea and vomiting continue 3 to 4 weeks after bone marrow transplantation(BMT). The treatment of CMV enteritis is not well established. We report a CMV duodenitis patient following allogenic bone marrow transplantation. The patient had prolonged nausea and vomiting for 5 weeks after bone marrow transplantation and CMV duodenitis was diagnosed by the gastroduodenoscopic mucosal biopsy which showed cytomegalic cells. Ganciclovir treatment for 3 weeks resulted in the resolution of symptoms and promoted healing of the lesion. The patient was free of CMV infection until 288 days after allogenic BMT without maintenance ganciclovir treatment.
Adult
;
Antiviral Agents/therapeutic use*
;
Bone Marrow Transplantation/adverse effects
;
Case Report
;
Cytomegalovirus Infections/etiology
;
Cytomegalovirus Infections/drug therapy*
;
Cytomegalovirus Infections/diagnosis
;
Duodenitis/etiology
;
Duodenitis/drug therapy*
;
Duodenitis/diagnosis
;
Ganciclovir/therapeutic use*
;
Human
;
Male
;
Transplantation, Homologous
2.A Case of Idiopathic Recurrent Duodenojejunitis.
Sung Yeol JANG ; Jung Hee KIM ; Sung Hae HA ; Jeong Ah HWANG ; Sang Jong PARK ; So Ya PAIK
The Korean Journal of Gastroenterology 2012;59(3):245-249
There are various etiologies of duodenojejunitis such as Henoch-Schonlein purpura (H-S purpura), vasculitis, Crohn's disease, celiac sprue, ischemia, lymphoma, Zollinger-Ellison syndrome, bacteria or parasite infection, radiation, drug induced jejunitis, eosinophilic jejunitis, and toxins. A 31-year-old man presented with left upper quadrant pain. He did not have febrile sense, hematochezia, melena, diarrhea, arthralgia and hematuria. He had neither drug history nor traveling history. Esophagogastroduodenoscopy showed diffuse mucosal erythema and segmental hemorrhagic erosions on the distal area to the descending portion of the duodenum and proximal jejunum, which were commonly observed in the gastrointestinal involvement of H-S purpura. However, he showed no skin lesions, joint and urologic problems until the discharge. Autoimmune markers such as antinuclear antibody and antineutrophil cytoplasmic antibody were negative. Celiac and mesenteric angiogram showed no vascular abnormality. After the administration of oral prednisolone 40 mg daily for therapeutic trial, abdominal pain and endoscopic lesions were improved. He experienced relapses of same episode without skin lesions 16 times during follow-up of 8 years, which were also treated with prednisolone. The abdominal computed tomography during the follow-up also showed no significant finding. We report a case of primary recurrent duodenojejunitis similar to the gastrointestinal involvement of H-S purpura without purpura.
Adult
;
Angiography
;
Anti-Inflammatory Agents/therapeutic use
;
Duodenitis/*diagnosis/drug therapy/pathology
;
Endoscopy, Gastrointestinal
;
Enteritis/*diagnosis/drug therapy/pathology
;
Humans
;
Jejunal Diseases/*diagnosis/drug therapy/pathology
;
Male
;
Prednisolone/therapeutic use
;
Purpura, Schoenlein-Henoch/diagnosis
;
Recurrence
3.Herpes Simplex Virus Duodenitis Accompanying Crohn's Disease.
Byung Hoo LEE ; Wook Hyun UM ; Seong Ran JEON ; Hyun Gun KIM ; Tae Hee LEE ; Wan Jung KIM ; Jin Oh KIM ; So Young JIN
The Korean Journal of Gastroenterology 2013;62(5):292-295
Herpes simplex virus (HSV) is a recognized cause of gastrointestinal infection in immunodeficient patients. Although a few cases of HSV gastritis and colitis in immunocompromised patients have been reported, there are no reports of HSV duodenitis in patients with Crohn's disease (CD). A 74-year-old female was admitted with general weakness and refractory epigastric pain. She had been diagnosed with CD three years ago. Esophagogastroduodenoscopy (EGD) revealed diffuse edematous and whitish mucosa with multiple erosions in the duodenum. Considering the possibility of viral co-infection, cytomegalovirus (CMV) immunohistochemical staining, PCR, and cultures of duodenal biopsies were performed, all of which were negative with the exception of the isolation of HSV in culture. After administration of intravenous acyclovir for 1 week, follow-up EGD showed almost complete resolution of the lesions and the patient's symptoms improved. In CD patients with refractory gastrointestinal symptoms, HSV, as well as CMV, should be considered as a possible cause of infection, so that the diagnosis of viral infection is not delayed and the appropriate antiviral treatment can be initiated.
Acyclovir/therapeutic use
;
Aged
;
Antiviral Agents/therapeutic use
;
Crohn Disease/complications/*diagnosis/virology
;
DNA, Viral/analysis
;
Duodenitis/complications/*diagnosis
;
Endoscopy, Digestive System
;
Female
;
Herpes Simplex/*diagnosis/drug therapy/virology
;
Humans
;
Intestinal Mucosa/pathology
;
Polymerase Chain Reaction
;
Simplexvirus/genetics/*isolation & purification
4.Study on efficacy of liujunzi decoction combined with zuojin pills in treating acute radioactive duodenitis and their mechanism.
Xiao CHEN ; Zhi-Qing WAN ; Gen-Cheng HAN ; Ji-Dong WANG ; Zhi ZHAO ; Ping ZHOU
China Journal of Chinese Materia Medica 2014;39(2):278-284
OBJECTIVETo evaluate the therapeutic effect of Liujunzi decoction combined with Zuojin pills in treating the radioactive duodenitis and their mechanism, and compare with clinical routine acid suppressants combined with mucous membrane protective preparations to study the mechanism of their efficacy.
METHODAccording to the study of Williams J P and characteristics of duodenitis, and by reference to the radiation enteritis modeling standard, we took the lead in establishing the mouse radioactive duodenal injury model. The model mice were randomly divided into the control group (n = 26), traditional Chinese medicine (TCM) group (n = 16) and the western medicine (oral administration with famotidine 0.5 mL + almagate suspension 0.3 mL per mouse, once a day) group (n = 16). After the standard administrating, such objective indexes as general condition, weight, changes in health score, pathology and expression of inflammatory factors were observed to evaluate the efficacy.
RESULTThe radioactive duodenitis model of mice was successfully established with 12 Gy. Mice in the control group suffered from weight loss, anorexia, low fluid intake, loose stools, and occasionally mucous bloody stool, poor spirit, dim fur, lack of exercise and arch back. Mice in drug intervention groups were generally better than those in the pure irradiation group. The IL-6, IL-1beta, TNF-alpha mRNA expressions in spleen and mesenteric lymph node tissues in TCM and western medicine groups showed a declining trend compared with the control group. Their concentrations in peripheral blood serum also slightly changed. The TCM group revealed notable advantage in reducing inflammatory factors. The microscopic observation showed that a better mucosa repair in intervention groups than the pure irradiation group. The improved Chiu's scoring method showed a statistical significance in the difference between TCM and western medicine groups (P < 0.05).
CONCLUSIONLiujunzi decoction combined with Zuojin pills could treat acute radiation enteritis, regulate organic immunity, and inhibit acute injury, promote local tissue repair, with the potential to resist such adverse effects as radiation intestinal fibrosis. The regulation of inflammatory factor release is one of efficacy generation mechanisms.
Animals ; Cobalt Radioisotopes ; adverse effects ; Drug Interactions ; Drugs, Chinese Herbal ; pharmacology ; therapeutic use ; Duodenitis ; blood ; drug therapy ; Interleukin-1beta ; blood ; Interleukin-6 ; blood ; Mice ; Mice, Inbred BALB C ; Mucous Membrane ; drug effects ; radiation effects ; Radiation Injuries, Experimental ; blood ; drug therapy ; Tumor Necrosis Factor-alpha ; blood